XM does not provide services to residents of the United States of America.

KKR to take 25% stake in Eni biofuel unit, valuing it at $13 bln



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-KKR to take 25% stake in Eni biofuel unit, valuing it at $13 bln</title></head><body>

KKR to buy 25% stake in Enilive for 2.94 bln euros

Deal adds credibility to Eni's 'satellite' strategy - analyst

Eni to inject 500 mln euros into Enilive

Adds KKR, analyst comments, background on Enilive

By Francesca Landini

MILAN, Oct 24 (Reuters) -U.S. fund KKR KKR.N is buying a 25% stake in Italian energy group Eni's ENI.MI biofuel business Enilive, in a deal that values the unit at 11.75 billion euros ($12.7 billion) including debt.

KKR's 2.94 billion euro purchase improves Eni's financial position while ensuring it retains control of Enilive, the Italian company said on Thursday.

The deal is part of Eni's so-called 'satellite' strategy to bring in co-investors to growth businesses. The strategy is aimed at raising funds to help Eni decarbonise its products.

"This agreement marks a significant further step in our business strategy related to the energy transition," Eni CEO Claudio Descalzi said.

The deal will be conducted via a 500 million euro capital increase for Enilive, which will be reserved for KKR, plus the sale of Enilive shares owned by Eni for 2.438 billion euros.

Eni will inject 500 million euros into Enilive before the deal closes, ensuring it is debt free.

"This (deal) aligns with our strategy to support transformative energy projects across Europe," said Alberto Signori, a partner in KKR's European Infrastructure team.

KKR has been investing in Italy since 2005 and recently finalised a deal to buy Telecom Italia's TLIT.MI fixed-line network.

SATELLITE STRATEGY

Royal Bank of Canada analyst Biraj Borkhataria said the deal added credibility to Eni's strategy following a similar transaction for another unit.

In March, Swiss asset manager Energy Infrastructure Partners agreed to take a minority stake in Eni's renewables subsidiary Plenitude.

Sources told Reuters last month that U.S. funds Stonepeak and Apollo were in talks with Eni over the potential sale of a second stake in Enilive.

Biofuels are expected to play a major role in decarbonising the truck, aviation and shipping sectors in coming years.

Enilive owns bio-refineries in Italy and abroad that produce biofuels using waste and vegetable oil partly from the group's agri-business in many African countries.

The subsidiary is expected to make core earnings of around 1.2 billion euros in 2025, up from 1 billion euros estimated for this year.

JP Morgan and Mediobanca were financial advisers for Eni. Deutsche Bank and UniCredit were financial advisers for KKR, with Kirkland & Ellis and Gianni & Origoni acting as legal counsel.

($1 = 0.9270 euros)



Reporting by Francesca Landini; Additional reporting by Claudia Cristoferi; Editing by David Goodman and Mark Potter

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.